Molecular Diagnostics
New AI Blood Test Could Become Game Changer for Bowel Cancer Diagnosis
Colorectal cancer (CRC), also referred to as bowel cancer, is the world's third most common cancer and the fourth leading cause of death. Now, the introduction of a fast, affordable, and scalable test for the early detection of bowel cancer could revolutionize the approach to the diagnosis and screening of this disease. More...10 Mar 2023
Blood Test Detects Alzheimer's with 97% Accuracy 10 Years Before Symptoms Emerge
A newly-developed blood test has the ability to detect Alzheimer's disease (AD)-associated pathology up to 10 years before the onset of symptoms with an impressive 97% accuracy rate. The test has enormous potential to create a positive impact on effective treatments for AD. More...10 Mar 2023
First Commercially Available Lab-Based Blood Test to Help Evaluate Concussion
Abbott Diagnostics has received U.S. Food and Drug Administration clearance for the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the U.S. More...08 Mar 2023
ApoB Protein Testing More Accurately Predicts Heart Disease Risk than Testing for Cholesterol Alone
Emerging data suggest that testing for levels of Apolipoprotein B-100 (ApoB), a protein responsible for transporting fat molecules including LDL cholesterol - notoriously known as the "bad cholesterol" - throughout the body, may be a more precise indicator of atherosclerotic cardiovascular disease. More...07 Mar 2023
Single Blood Test Detects Various Tumor Types Less Invasively Than Tissue Biopsy
Around 40% of childhood cancers are pediatric solid tumors. Although pediatric cancer is uncommon, children can develop various tumor types in different body parts, making differential diagnosis difficult. Now, a newly developed liquid biopsy for solid tumors could be highly beneficial in cases where surgery or a tissue biopsy is not possible, potentially enabling more targeted diagnoses. More...06 Mar 2023
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Automated MALDI-TOF MS System
EXS 3000
In Other News
Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy
New Method to Detect RNA Viruses More Effective and Faster than PCR Test
Revolutionary Blood Test Enables Early Detection of Coronary Heart Disease
New Device That Detects Cancer Cells Could Help Avoid Invasive Biopsy Surgeries
Blood Test Could Diagnose Brain Cancer, Track Progression and Guide Treatment
AI Accurately Predicts Cardiovascular Disease by Examining Genes in DNA of Heart Patients
Novel Saliva Collection Device Keeps Analytes Stable at Ambient Temperatures for Weeks
New Ultrafast 5-Minute PCR Technology Faster Than Self-Diagnosis Kits
Blood Test to Measure Key Molecule Could Help Diagnose Vascular Dementia
Compact POCT Platform Unlocks Multiplexing Potential of Real-Time PCR
Portable Real-Time PCR System Resolves Problems of Limited Lab Space and Fragmented Samples
Simple Blood Tests for Signaling Proteins Could Predict Cancer or Inflammation
Recombinant ELISAs Increase Efficiency of CMV Serodiagnosis in Pregnant Women
Novel Esophageal Cancer Test Could Reduce Unnecessary Endoscopies
Non-Invasive Stool Test Could Diagnose Early Form of Parkinson’s Disease
Benchtop Multiplex Genetic Analyzer Helps Target, Identify, and Confirm Clinically Relevant Mutations
New Technique Designs Nucleic Acid Probes to Detect Rapidly Mutating Bacteria and Viruses
New Study to Help Identify Accurate microRNA Biomarkers for Early Detection and Treatment of Diabetes
D-Dimer Blood Test Detects Prosthetic Joint Infections as Accurately as Standard Tests
New Diagnostic Test 1,000 Times More Sensitive than Conventional Tests
Unique Biomarker Could Lead to Diagnostic Tests for Detection of Early-Stage Alzheimer’s
Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.